Abstract

PDB74 - Cost-effectiveness of switching to biphasic insulin aspart from human premix insulin in people with type 2 diabetes in China

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Premixed insulin treatment for type 2 diabetes: analogue or human?
Alan J Garber ... Jens S Christiansen
Diabetes, obesity & metabolism | VOL. 9
Alan J Garber, et. al.Alan J Garber ... Jens S Christiansen
08 Sep 2006
English
Abhishek Singhai ... Pragya Jain
Journal of Evolution of Medical and Dental sciences | VOL. 2
Abhishek Singhai, et. al.Abhishek Singhai ... Pragya Jain
12 Jan 2013
Cost-Effectiveness of Biphasic Insulin Aspart 30 VS. Human Premix Insulin in Type 2 Diabetes from the Payer's Perspective in Bulgaria
Vasil Valov ... Guenka Petrova
Biotechnology & Biotechnological Equipment | VOL. 26
Vasil Valov, et. al.Vasil Valov ... Guenka Petrova
01 Jan 2012
A direct efficacy and safety comparison of insulin aspart, human soluble insulin, and human premix insulin (70/30) in patients with type 2 diabetes.
Reinhard G Bretzel ... JüRgen Medding
Diabetes care | VOL. 27
Reinhard G Bretzel, et. al.Reinhard G Bretzel ... JüRgen Medding
26 Apr 2004
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
How many Monte Carlo samples are needed for probabilistic cost-effectiveness analyses?
Reza Yaesoubi
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Reza YaesoubiReza Yaesoubi
06 Jul 2024
Three Pillars of Support for Orphan Drug Programs: Individual Valuations, Societal Valuations, and Anonymous Altruism
Darius N Lakdawalla ... Hong-Hanh Nguyen
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Darius N Lakdawalla, et. al.Darius N Lakdawalla ... Hong-Hanh Nguyen
06 Jul 2024
EQ-5D-5L population scores in mainland China: results from a nationally representative survey 2021
Qiang Yao ... Chaojie Liu
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Qiang Yao, et. al.Qiang Yao ... Chaojie Liu
06 Jul 2024
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
View more papers